From professional translators, enterprises, web pages and freely available translation repositories.
oxaliplatin
oxaliplatin
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
oxaliplatin fl-ewwel ġurnata
oxaliplatin on day 1
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oxaliplatin Ġurnata, kull 3 ġimgħat
oxaliplatin on day 1, every 3 weeks
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oxaliplatin fl-ewwel Ġurnata, kull
oxaliplatin on day 1, every 2 weeks
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oxaliplatin fl- ewwel Ġurnata, kull ġimagħtejn
oxaliplatin on day 1, every 2 weeks leucovorin on days 1 and 2, every 2
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
oxaliplatin fl- ewwel Ġurnata capecitabine orali bid għal
oxaliplatin on day 1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
flimkien ma’ kimoterapija bbażata fuq irinotecan jew oxaliplatin:
in combination with irinotecan- or oxaliplatin-based chemotherapy:
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oxaliplatin Ġurnata, kull 3 ġimgħat capecitabine mill- ħalq darbtejn
oxaliplatin capecitabine
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
kimoterapija bbażata fuq fluoropyrimidine/irinotecan jew fluoropyrimidine/oxaliplatin
fluoropyrimidine/irinotecan or fluoropyrimidine/oxaliplatin based chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
oxaliplatin fl- ewwel Ġurnata leucovorin fl- ewwel u fit- tieni
oxaliplatin on day 1
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ikkombinat ma’ bevacizumab u kimoterapija bbażata fuq oxaliplatin jew irinotecan bħala trattament tal-ewwel għażla
first-line combination with bevacizumab and oxaliplatin or irinotecan-based chemotherapy
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sorafenib ma kellu l- ebda effett fuq il- farmakokinetika ta ’ gemcitabine jew ta ’ oxaliplatin.
sorafenib had no effect on the pharmacokinetics of gemcitabine or oxaliplatin.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
il-pazjenti kollha irċevew kura minn qabel b’kimoterapija bbażata fuq fluoropyrimidine, oxaliplatin, u irinotecan.
all patients received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
zaltrap ġie investigat fi studju prinċipali wieħed li kien jinvolvi 1,226 adult b'kanċer kolorettali metastatiku li ma kinux wieġbu għal kura bbażata fuq oxaliplatin.
zaltrap was investigated in one main study involving 1,226 adults with metastatic colorectal cancer that had not responded to oxaliplatin-based treatment.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
capecitabine intuża wkoll f’taħlita ma’ oxaliplatin għall-kura ta’ kanċer avvanzat tal-istonku.
capecitabine has also been used in combination with oxaliplatin for the treatment of advanced gastric cancer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
l-użu ta’ kors li fih irinotecan jew oxaliplatin kien maqlub skont l-użu ta’ oxaliplatin jew irinotecan bħala kura preferita.
use of irinotecan- or oxaliplatin-containing regimen was switched depending on first-line usage of either oxaliplatin or irinotecan.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
l-oġġettiv maġġuri tal-istudju kien il-paragun ta’ pfs fil-ko-orti ta’ oxaliplatin.
the major study objective was comparison of pfs in the oxaliplatin cohort.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
capecitabine intuża wkoll f’taħlita ma’ oxaliplatin għall-kura ta’ kanċer avvanzat ta’ l-istonku.
capecitabine has also been used in combination with oxaliplatin for the treatment of advanced gastric cancer.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
eof: epirubicin (50 mg/ m2 bħala bolus fl- ewwel jum kull 3 ġimgħat), oxaliplatin (130 mg/ m2
- eof: epirubicin (50 mg/ m2 as a bolus on day 1 every 3 weeks), oxaliplatin (130 mg/ m2 given as
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
il-medjan tas-sopravvivenza globali kien ta’ 10.0 xhur f’korsijiet bbażati fuq cisplatin u 10.4 xhur f’korsijiet bbażati fuq oxaliplatin.
the median overall survival was 10.0 months in cisplatin-based regimens and 10.4 months in oxaliplatin- based regimens.
Last Update: 2017-04-26
Usage Frequency: 6
Quality: